High-sensitive Troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation

[1]  S. Lewandowsky.  PLOS ONE 2013 , 2015 .

[2]  Jeroen J. Bax,et al.  The universal definition of myocardial infarction , 2015, Oxford Medicine Online.

[3]  P. Thokala,et al.  Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation. , 2013, Health technology assessment.

[4]  David E Newby,et al.  Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction , 2012, Heart.

[5]  J. Wildberger,et al.  High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort , 2012, PloS one.

[6]  M. Sculpher,et al.  Catalogue of EQ-5D Scores for the United Kingdom , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  H. Katus,et al.  High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.

[8]  F. D. de Charro,et al.  Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial , 2010, Current medical research and opinion.

[9]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[10]  Harlan M Krumholz,et al.  Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study , 2009, BMJ : British Medical Journal.

[11]  Bernie Smith,et al.  Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. , 2008, European heart journal.

[12]  P. Serruys,et al.  Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Long-Term Outcome After Bare Metal and Drug-Eluting Stent Implantation , 2008, Circulation. Cardiovascular interventions.

[13]  J. Reitsma,et al.  Incidence of first acute myocardial infarction in the Netherlands. , 2007, The Netherlands journal of medicine.

[14]  M. Aalabaf-Sabaghi.  Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.

[15]  T. Szekeres,et al.  Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. , 2007, QJM : monthly journal of the Association of Physicians.

[16]  Sidney C. Smith,et al.  Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. , 2007, The American journal of cardiology.

[17]  Lars Edenbrandt,et al.  Direct hospital costs of chest pain patients attending the emergency department: a retrospective study , 2006, BMC emergency medicine.

[18]  Elisabeth Fenwick,et al.  Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation , 2006, BMC Health Services Research.

[19]  H. Selker,et al.  Acute coronary syndromes in the emergency department: diagnostic characteristics, tests, and challenges. , 2005, Cardiology clinics.

[20]  W. Hermens,et al.  Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[21]  S. Halvorsen,et al.  Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction , 2005, Scandinavian cardiovascular journal : SCJ.

[22]  J. Ornato,et al.  A comprehensive strategy for the evaluation and triage of the chest pain patient: A cost comparison study , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[23]  R Ruthazer,et al.  Missed diagnoses of acute cardiac ischemia in the emergency department. , 2000, The New England journal of medicine.

[24]  I. Menown,et al.  Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. , 2000, European heart journal.

[25]  Eric Boersma,et al.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[26]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[27]  P Thokala,et al.  Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. , 2013, Health technology assessment.

[28]  Michael Marber,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction , 2010 .

[29]  O. Tiemann.  Variations in Hospitalisation Costs for Acute Myocardial Infarction - A Comparison Across Europe , 2008, Health economics.

[30]  Milton C Weinstein,et al.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.